Literature DB >> 20880547

The effects of comorbid personality disorders on cognitive behavioral treatment for panic disorder.

Michael J Telch1, Jan H Kamphuis, Norman B Schmidt.   

Abstract

The present study investigated the influence of personality pathology assessed both dimensionally and categorically on acute clinical response to group cognitive-behavioral treatment in a large sample of panic disorder patients (N = 173) meeting DSMIII-R criteria for panic disorder with or without agoraphobia. Nearly one-third of the sample met for one or more personality disorders, with the majority meeting for a Cluster C diagnosis. Patients with one or more comorbid personality disorders displayed higher baseline and higher post treatment scores across multiple indices of panic disorder severity compared to those without personality disorders. After controlling for panic disorder severity at baseline, the presence of both Cluster C and Cluster A Pers-Ds predicted a poorer outcome, whereas when assessed dimensionally, only Cluster C symptoms predicted a poorer treatment response. However, the influence of personality pathology was modest relative to that of baseline panic disorder severity.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20880547     DOI: 10.1016/j.jpsychires.2010.08.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

1.  Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study.

Authors:  Wessel A van Eeden; Albert M van Hemert; Erik J Giltay; Philip Spinhoven; Edwin de Beurs; Ingrid V E Carlier
Journal:  J Nerv Ment Dis       Date:  2022-04-23       Impact factor: 1.899

2.  Patient characteristics and variability in adherence and competence in cognitive-behavioral therapy for panic disorder.

Authors:  James F Boswell; Matthew W Gallagher; Shannon E Sauer-Zavala; Jacqueline Bullis; Jack M Gorman; M Katherine Shear; Scott Woods; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2013-01-21

3.  Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders.

Authors:  Marie Ociskova; Jan Prasko; Dana Kamaradova; Ales Grambal; Petra Kasalova; Zuzana Sigmundova; Klara Latalova; Kristyna Vrbova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-15       Impact factor: 2.570

4.  Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.

Authors:  Marie Ociskova; Jan Prasko; Klara Latalova; Dana Kamaradova; Ales Grambal
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-24       Impact factor: 2.570

5.  Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety.

Authors:  Rahil Sanatinia; Duolao Wang; Peter Tyrer; Helen Tyrer; Mike Crawford; Sylvia Cooper; Gemma Loebenberg; Barbara Barrett
Journal:  Br J Psychiatry       Date:  2016-07-21       Impact factor: 9.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.